Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment-Reference-Cited by-同舟云学术

Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment

Published:2021-12-22 Issue:3 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Cao Demin¹²,Liu Weihua³,Lyu Na¹,Li Boxing¹,Song Weibo⁴,Yang Yanxiao⁵,Zhu Jianliang³,Zhang Zhiguo⁶,Zhu Baoli¹²⁷^ORCID

Affiliation:

1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

2. University of Chinese Academy of Sciences, Beijing, China

3. Shijiazhuang Center for Disease Control and Prevention, Hebei, China

4. Gaocheng District Center for Disease Control and Prevention in Shijiazhuang, Hebei, China

5. Gaocheng People's Hospital in Shijiazhuang, Hebei, China

6. Beijing Changping Institute for Tuberculosis Prevention and Treatment, Beijing, China

7. Department of Pathogenic Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, China

Abstract

Numerous studies have shown that the gut bacterial microbiota is altered in active TB patients and that anti-TB drugs have profound and long-term impacts. However, as an integral part of the microbiota, fungi have rarely been studied.

Funder

Beijing Science and Technology Planning Project

MOST | National Key Research and Development Program of China

National Natural Science Foundation of China

Strategic Priority Research Program of the Chinese Academy of Sciences

Beijing Municipal Science and Technology Commission

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00615-21

Reference56 articles.

1. WHO. 2021. Global tuberculosis report (2020). World Health Organization. https://www.who.int/.

2. Gut Mycobiota in Immunity and Inflammatory Disease

3. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity

4. The role of the microbiota in infectious diseases

5. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The characteristics of the gut microbiota in patients with pulmonary tuberculosis: A systematic review;Diagnostic Microbiology and Infectious Disease;2024-07

2. Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies;Molecules;2024-06-04

3. Gut Microbiota and Pulmonary Tuberculosis (Literature Review);Tuberculosis and Lung Diseases;2024-05-02

4. Alterations in the gut mycobiome with coronary artery disease severity;eBioMedicine;2024-05

5. Synthesis of narrow-spectrum anti-mycobacterial molecules without effect on the diversity of gut microbiota in mice based on the structure of rifampicin;Bioorganic Chemistry;2024-05